A study in CKD patients with cardiomyopathy reported that the severity of left ventricular hypertrophy and left ventricular dysfunction correlates in a dose dependent manner with the R allele in the PON-1 polymorphism Q192R [54]. The gene discussed is PON1; the disease is cardiomyopathy.